Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening

Medicin og biovidenskab

• Triple Negative Breast Neoplasms 100%
• Preclinical Drug Evaluations 98%
• Neoplastic Stem Cells 88%
• Neoplasms 26%
• Catenins 17%
• Apoptosis 12%
• Death Domain 9%
• Apoptosis Regulatory Proteins 8%
• Drug Development 6%
• Proteomics 6%
• Organism Cloning 6%
• Interleukin-2 6%
• Clone Cells 5%
• B-Lymphocytes 5%
• Cell Survival 5%
• Cell Death 5%
• Cell Count 5%
• Proteins 5%
• Stem Cells 5%
• Epithelial Cells 4%
• Light 4%
• Down-Regulation 4%
• Phenotype 4%
• Cell Line 4%
• Therapeutics 1%